BC
GILD icon

Brinker Capital’s Gilead Sciences GILD Stock Holding History

Brinker Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$3.05M Buy
39,687
+23,928
+152% +$1.83M 0.1% 205
2020
Q1 		$1.18M Buy
+15,759
New +$1.09M 0.05% 378
2019
Q3 		– Sell
-20,408
Closed -$1.38M – 948
2019
Q2 		$1.38M Sell
20,408
-1,839
-8% -$121K 0.05% 375
2019
Q1 		$1.45M Sell
22,247
-2,240
-9% -$149K 0.05% 356
2018
Q4 		$1.53M Sell
24,487
-633
-3% -$44.2K 0.07% 281
2018
Q3 		$1.94M Sell
25,120
-2,029
-7% -$153K 0.07% 293
2018
Q2 		$1.92M Buy
27,149
+710
+3% +$50.1K 0.07% 280
2018
Q1 		$1.99M Buy
26,439
+2,556
+11% +$203K 0.08% 261
2017
Q4 		$1.71M Buy
23,883
+487
+2% +$37K 0.07% 279
2017
Q3 		$1.9M Buy
23,396
+202
+0.9% +$15.4K 0.08% 242
2017
Q2 		$1.64M Buy
23,194
+1,494
+7% +$99.4K 0.08% 265
2017
Q1 		$1.47M Sell
21,700
-6,567
-23% -$462K 0.07% 267
2016
Q4 		$2.02M Buy
28,267
+21,687
+330% +$1.61M 0.11% 184
2016
Q3 		$521K Buy
6,580
+85
+1% +$6.91K 0.05% 191
2016
Q2 		$542K Sell
6,495
-355
-5% -$31.5K 0.05% 195
2016
Q1 		$629K Sell
6,850
-208
-3% -$18.8K 0.05% 138
2015
Q4 		$714K Buy
+7,058
New +$734K 0.06% 103
2015
Q2 		– Sell
-4,625
Closed -$454K – 114
2015
Q1 		$454K Sell
4,625
-234
-5% -$23.8K 0.04% 125
2014
Q4 		$458K Sell
4,859
-1,168
-19% -$121K 0.04% 139
2014
Q3 		$642K Buy
6,027
+70
+1% +$6.85K 0.05% 72
2014
Q2 		$493K Buy
5,957
+601
+11% +$46.8K 0.03% 108
2014
Q1 		$379K Sell
5,356
-941
-15% -$73.8K 0.03% 129
2013
Q4 		$472K Sell
6,297
-80
-1% -$5.57K 0.04% 97
2013
Q3 		$400K Sell
6,377
-207
-3% -$12.4K 0.04% 99
2013
Q2 		$337K Buy
+6,584
New +$343K 0.04% 112

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Brinker Capital's GILD Position: Q2 2020 in Review

Brinker Capital increased its Gilead Sciences (GILD) stake by 152% in Q2 2020, buying an estimated $1.83M and bringing the position to 39,687 shares worth $3.05M. The position accounts for 0.1% of the portfolio, ranked #205.

Brinker Capital first reported a position in GILD in Q2 2013 and has held it in 25 quarters since. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Brinker Capital held 39,687 shares of Gilead Sciences worth $3.05M as of Q2 2020.
  • Brinker Capital bought 23,928 Gilead Sciences shares in Q2 2020, an estimated $1.83M.
  • Gilead Sciences made up 0.1% of Brinker Capital's portfolio in Q2 2020, its #205 holding.
  • Brinker Capital first reported a position in Gilead Sciences in Q2 2013 and has held it in 25 quarters since.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.